Edwards Lifesciences Corp (EW)vsSpectral AI Inc. (MDAI)
EW
Edwards Lifesciences Corp
$85.96
-1.70%
HEALTHCARE · Cap: $49.01B
MDAI
Spectral AI Inc.
$1.89
-5.97%
HEALTHCARE · Cap: $64.60M
Smart Verdict
WallStSmart Research — data-driven comparison
Edwards Lifesciences Corp generates 37124% more annual revenue ($6.30B vs $16.93M). EW leads profitability with a 17.4% profit margin vs -82.0%. EW earns a higher WallStSmart Score of 61/100 (C+).
EW
Buy61
out of 100
Grade: C+
MDAI
Avoid17
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+68.7%
Fair Value
$253.29
Current Price
$85.96
$167.33 discount
Margin of Safety
-2.7%
Fair Value
$1.50
Current Price
$1.89
$0.39 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Strong operational efficiency at 31.2%
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
16.7% revenue growth
Conservative balance sheet, low leverage
Areas to Watch
Expensive relative to growth rate
Weak financial health signals
Premium valuation, high expectations priced in
Negative free cash flow — burning cash
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -2308.0% — below average capital efficiency
Revenue declined 40.5%
Comparative Analysis Report
WallStSmart ResearchBull Case : EW
The strongest argument for EW centers on Operating Margin, Debt/Equity, Altman Z-Score. Profitability is solid with margins at 17.4% and operating margin at 31.2%. Revenue growth of 16.7% demonstrates continued momentum.
Bull Case : MDAI
The strongest argument for MDAI centers on Debt/Equity.
Bear Case : EW
The primary concerns for EW are PEG Ratio, Piotroski F-Score, P/E Ratio. A P/E of 46.0x leaves little room for execution misses.
Bear Case : MDAI
The primary concerns for MDAI are EPS Growth, Market Cap, Return on Equity.
Key Dynamics to Monitor
EW profiles as a growth stock while MDAI is a turnaround play — different risk/reward profiles.
MDAI carries more volatility with a beta of 1.16 — expect wider price swings.
EW is growing revenue faster at 16.7% — sustainability is the question.
MDAI generates stronger free cash flow (-7M), providing more financial flexibility.
Bottom Line
EW scores higher overall (61/100 vs 17/100), backed by strong 17.4% margins and 16.7% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Edwards Lifesciences Corp
HEALTHCARE · MEDICAL DEVICES · USA
Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring.
Visit Website →Spectral AI Inc.
HEALTHCARE · MEDICAL DEVICES · USA
Spectral MD Holdings, Ltd., a predictive analytics company, develops AI algorithms and optical technology in wound care treatment. The company is headquartered in Dallas, Texas.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?